Coronary Stent Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Global Coronary Stent Market is segmented by Product Type (Drug-eluting Stent, Bare Metal Coronary Stent, and Bioabsorbable Stent), Biomaterial, End User, and Geography

Market Snapshot

Coronary Stent Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %
Coronary Stent Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors found propelling the growth of the market include the increasing prevalence of coronary artery diseases (CADs), rising the geriatric population, and the technological advancements in coronary stents.

The prevalence of coronary artery disease (CAD) increased in the past three decades in low- and middle-income countries, including India. Coronary artery disease is responsible for 20% of the total deaths in India. Thus, with the increased burden of CAD, the usage of coronary stents has increased significantly in healthcare facilities, as well as their production by the medical device manufacturers, thus helping in driving the market growth. In addition, the increasing geriatric population also increased the demand for coronary stents that are expected to rise over the forecast period.

There has also been a high demand for minimally invasive surgical procedures, which significantly drives the coronary stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized coronary stents.

Scope of the Report

As per the scope of the report, coronary stents are small elastic tubes used for the treatment of narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina) and aid in the treatment of a heart attack. These types of stents are also called as heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty.

Product Type
Drug Eluting Stent
Bare Metal Coronary Stent
Bioabsorbable Stent
By Biomaterial
Mettalic Biomaterial
Polymeric Biomaterial
Natual Biomaterial
End User
Ambulatory Surgical Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Drug-eluting Stent is the Largest Segment by Product Type, Expected to do Same Over the Forecast Period

The drug-eluting stent segment has accounted for the largest revenue, as it can be used for the treatment of a large number of disorders, such as diabetes, renal disease, percutaneous coronary intervention, and ST-segment elevation myocardial infarction (STEMI). There are also various technological advances seen in the drug-eluting stent segment that may witness tremendous growth.

According to a survey conducted by European Heart Network in 2017, 3.9 million deaths in Europe were due to cardiovascular diseases. The increasing prevalence of cardiovascular diseases is also a major factor in the growth of the segment.

Coronary Stent Market Key Trends

North America Experienced the Largest Growth and is Expected to Follow the Same Trend Over the Forecast Period

North America holds the largest market share for coronary stents due to the dominance of the top companies present in the global market. There is also an increase in the aging population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market. According to the American College of Cardiology (2017), Cardiovascular disease accounts for 800,000 deaths in the United States. The increasing patient pool is boosting the market growth in the region.

Coronary Stent Market Growth by Region

Competitive Landscape

The major companies adopted strategies, like mergers and acquisitions and strategic alliances, to gain a competitive advantage in the market. Additionally, companies are also more focused on the development of technologically advanced products, which deliver greater accuracy and efficiency.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)

      2. 4.2.2 Rising of the Geriatric Population

      3. 4.2.3 Technological Advancements in Coronary Stents

    3. 4.3 Market Restraints

      1. 4.3.1 High Product Recalls

      2. 4.3.2 Stringent Approval Process for Stents

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Product Type

      1. 5.1.1 Drug Eluting Stent

      2. 5.1.2 Bare Metal Coronary Stent

      3. 5.1.3 Bioabsorbable Stent

    2. 5.2 By Biomaterial

      1. 5.2.1 Mettalic Biomaterial

      2. 5.2.2 Polymeric Biomaterial

      3. 5.2.3 Natual Biomaterial

    3. 5.3 End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 B. Braun Medical Inc.

      3. 6.1.3 Biosensors International Group Ltd

      4. 6.1.4 BIOTRONIK SE & Co. KG

      5. 6.1.5 Boston Scientific Corporation

      6. 6.1.6 Cook Medical Technologies

      7. 6.1.7 Medtronic PLC

      8. 6.1.8 Terumo Corporation

      9. 6.1.9 Translumina GmbH

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Coronary Stent Market market is studied from 2018 - 2026.

The Coronary Stent Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories, B. Braun Medical Inc., Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, Boston Scientific Corporation are the major companies operating in Coronary Stent Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!